Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia
Open Access
- 2 March 2020
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 10 (3) , 384
Abstract
Schizophrenia is a neurodevelopmental disorder featuring chronic, complex neuropsychiatric features. The etiology and pathogenesis of schizophrenia are not fully understood. Oxidative-antioxidant imbalance is a potential determinant of schizophrenia. Oxidative, nitrosative, or sulfuric damage to enzymes of glycolysis and tricarboxylic acid cycle, as well as calcium transport and ATP biosynthesis might cause impaired bioenergetics function in the brain. This could explain the initial symptoms, such as the first psychotic episode and mild cognitive impairment. Another concept of the etiopathogenesis of schizophrenia is associated with impaired glucose metabolism and insulin resistance with the activation of the mTOR mitochondrial pathway, which may contribute to impaired neuronal development. Consequently, cognitive processes requiring ATP are compromised and dysfunctions in synaptic transmission lead to neuronal death, preceding changes in key brain areas. This review summarizes the role and mutual interactions of oxidative damage and impaired glucose metabolism as key factors affecting metabolic complications in schizophrenia. These observations may be a premise for novel potential therapeutic targets that will delay not only the onset of first symptoms but also the progression of schizophrenia and its complications.Keywords
Funding Information
- Uniwersytet Jagielloński Collegium Medicum (N41/DBS/000292)
This publication has 276 references indexed in Scilit:
- Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studiesTranslational Psychiatry, 2012
- Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative ViewAntioxidants & Redox Signaling, 2011
- Toll-like receptor signaling in neural plasticity and diseaseTrends in Neurosciences, 2011
- Impact of DISC1 variation on neuroanatomical and neurocognitive phenotypesMolecular Psychiatry, 2011
- Antipsychotic drugs and obesityTrends in Molecular Medicine, 2011
- Oxidative stress in schizophrenia: An integrated approachNeuroscience & Biobehavioral Reviews, 2011
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and StressMolecular Cell, 2010
- Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesisProceedings of the National Academy of Sciences, 2010
- Altered Lipid Metabolism in Brain Injury and Disorders2008
- Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's diseaseNucleic Acids Research, 2007